Orange Book product · Generic (ANDA)
SUMATRIPTAN AND NAPROXEN SODIUM
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Generic (ANDA)ANDA 207457TE ABRX AUROBINDO PHARMA LTD
At a glance
Feb 15, 2018
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 15, 2018
8 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Strength
500MG;EQ 85MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 207457
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
